Medi-Tech Insights Get in touch

CAR T-cell Therapy Market Size, Share, Trends, Demand, Industry Growth Analysis and Forecast 2024

Request Quote Download FREE Sample
Single User

Table of Contents

  1. Introduction
    • Introduction
    • Market Scope
      • Market Definition
      • Segments Covered
      • Regional Segmentation
    • Research Timeframe
    • Currency Considered
    • Study Limitations
    • Stakeholders
    • List of Abbreviations
    • Key Conferences and Events (2023-2024)
  2. Research Methodology
    • Secondary Research
    • Primary Research
    • Market Estimation
      • Bottom-Up Approach
      • Top-Down Approach
    • Market Forecasting
  3. Executive Summary
    • CAR T-cell Therapy Marke"4">
    • Market Overview
      • Market Dynamics
        • Drivers
          • The rising prevalence of cancer worldwide
          • Advancements in CAR T-cell technology
          • Strong pipeline of CAR T-cell therapies
          • Growing strategic collaborations and partnerships
          • Increase in R&D investments for new CAR T-cell therapies
          • High efficacy of CAR T-cell therapy
        • Restraints
          • High cost of therapy
          • Complex manufacturing process
          • Potential for severe side effects
          • Limited availability of treatment centers
        • Opportunities
          • Expansion into solid tumors
          • Development of allogeneic CAR T-cell therapies
          • Combination therapies
        • Key Market Trends
          • Next-generation CAR T-cells
          • Combination therapies
          • Manufacturing advancements
        • Unmet Market Needs
        • Pipeline Analysis
        • Industry Spea
  1. Global CAR T-cell Therapy Market Size & Forecast (2022-2029), By Product Type, USD Million
    • Introduction
    • Abecma
    • Breyanzi
    • Carvykti
    • Yescarta
    • Tecartus
    • Kymriah
    • Others
  2. Global CAR T-cell Therapy Market Size & Forecast (2022-2029), By Indication Type, USD Million
    • Introduction
    • Multiple Myeloma
    • B-cell Lymphoma
    • Acute Lymphoblastic Leukemia
    • Others
  3. Global CAR T-cell Therapy Market Size & Forecast (2022-2029), By Target Type, USD Million
    • Introduction
    • BCMA
    • CD19
    • Others
  4. CAR T-cell Therapy Market Size & Forecast (2022-2029), By End User Type
    • Introduction
    • Hospitals
    • Long-term Care Facilities
    • Specialty Centers
    • Others
  5. Global CAR T-cell Therapy Market Size & Forecast (2022-2029), By Region, USD Million
    • Introduction
    • North America CAR T-cell Therapy Market Size & Forecast (2022-2029), By Country, USD Million
      • US
        • Market Size & Forecast, By Product Type (USD Million)
        • Market Size & Forecast, By Indication Type (USD Million)
        • Market Size & Forecast, By Target Type (USD Million)
        • Market Size & Forecast, By End User Type (USD Million)
      • Canada
        • Market Size & Forecast, By Product Type (USD Million)
        • Market Size & Forecast, By Indication Type (USD Million)
        • Market Size & Forecast, By Tai>
      • Europe CAR T-cell Therapy Market Size & Forecast (2022-2029), By Country, USD Million
        • UK
          • Market Size & Forecast, By Product Type (USD Million)
          • Market Size & Forecast, By Indication Type (USD Million)
          • Market Size & Forecast, By Target Type (USD Million)
          • Market Size & Forecast, By End User Type (USD Million)
        • Germany
          • Market Size & Forecast, By Product Type (USD Million)
          • Market Size & Forecast, By Indication Type (USD Million)
          • Market Size & Forecast, By Target Type (USD Million)
          • Market Size & Forecast, By End User Type (USD Million)
        • France
          • Market Size & Forecast, By Product Type (USD Million)
          • Market Size & Forecast, By Indication Type (USD Million)
          • Market Size & Forecast, By Target
          • Italy
            • Market Size & Forecast, By Product Type (USD Million)
            • Market Size & Forecast, By Indication Type (USD Million)
            • Market Size & Forecast, By Target Type (USD Million)
            • Market Size & Forecast, By End User Type (USD Million)
          • Spain
            • Market Size & Forecast, By Product Type (USD Million)
            • Market Size & Forecast, By Indication Type (USD Million)
            • Market Size & Forecast, By Target Type (USD Million)
            • Market Size & Forecast, By End User Type (USD Million)
          • Rest of Europe
            • Market Size & Forecast, By Product Type (USD Million)
            • Market Size & Forecast, By Indication Type (USD Million)
            • Market Size & Forecast, By Target Type (USD Million)
            • Market Size & Forecast, By End User Type (USD Million)
            • China
              • Market Size & Forecast, By Product Type (USD Million)
              • Market Size & Forecast, By Indication Type (USD Million)
              • Market Size & Forecast, By Target Type (USD Million)
              • Market Size & Forecast, By End User Type (USD Million)
            • Japan
              • Market Size & Forecast, By Product Type (USD Million)
              • Market Size & Forecast, By Indication Type (USD Million)
              • Market Size & Forecast, By Target Type (USD Million)
              • Market Size & Forecast, By End User Type (USD Million)
            • India
              • Market Size & Forecast, By Product Type (USD Million)
              • Market Size & Forecast, By Indication Type (USD Million)
              • Market Size & Forecast, By Target Type (USD Million)
              • Market Size & Forecast, By End User Type (USD Million)<>Market Size & Forecast, By Indication Type (USD Million)
              • Market Size & Forecast, By Target Type (USD Million)
              • Market Size & Forecast, By End User Type (USD Million)
            • Latin America (LATAM) CAR T-cell Therapy Market Size & Forecast (2022-2029), USD Million
              • Market Size & Forecast, By Product Type (USD Million)
              • Market Size & Forecast, By Indication Type (USD Million)
              • Market Size & Forecast, By Target Type (USD Million)
              • Market Size & Forecast, By End User Type (USD Million)
            • Middle East & Africa (MEA) CAR T-cell Therapy Market Size & Forecast (2022-2029), USD Million
              • Market Size & Forecast, By Product Type (USD Million)
              • Market Size & Forecast, By Indication Type (USD Million)
              • Market Size & Forecast, By Target Type (USD Million)
              • Market Sili>
  1. Competitive Landscape
    • Key Players and their Competitive Positioning
      • Key Player Comparison
      • Segment-wise Player Mapping
      • Market Share Analysis (2023)
      • Company Categorization Matrix
        • Dominants/Leaders
        • New Entrants
        • Emerging Players
        • Innovative Players
      • Key Strategies Assessment, By Player (2022-2024)
        • New Product Launches
        • Partnerships, Agreements, & Collaborations
        • Mergers & Acquisitions
        • Geographic Expansion
  1. Company Profiles*

(Business Overview, Financial Performance**, Products Offered, Recent Developments)

  • Allogene Therapeutics, Inc.
  • Autolus Therapeutics
  • Bristol-Myers Squibb Company
  • CARsgen Therapeutics Holdings Ltd
  • Gilead Sciences, Inc.
  • ImmunoACT
  • IASO Biotherapeutics
  • Johnson & Johnson
  • JW (Cayman) Therapeutics Co Ltd
  • Novartis AG
  • Other Prominent Players

Related Reports

View All Research Reports